The Latest Breaking News from Barchart

Virginia-based Indivior, a developer of opioid addiction treatments, continues to hold down a place in Barchart’s Top 100 Stocks to Buy. Up 192% in 2025, its P/E is declining despite the stock’s gains over the past year. Here’s why.

Barrick Gold is up big as gold prices continue to hit new records.

Lumentum (LITE) has surged 340% over the past year, driven by strong technical momentum. The stock recently set a new 10-year high. Shares maintain a 100% “Buy” opinion from Barchart. Analyst sentiment is bullish, with most rating LITE a “Strong Buy” although price targets vary widely. Today’s Featured Stock Valued...

Costco Wholesale Corp reported strong free cash flow and FCF margins on Dec. 11. However, COST stock has tumbled, down 8.7% over the last year. That makes COST stock attractive to value investors and could be a bargain here.

These stocks offer dividend growth, fair payout ratios, and analyst buy ratings.

Teva Pharmaceutical (TEVA) is trading at new 5-year highs. Shares are up more than 40% over the past year. The stock has strong technical momentum, maintaining a 100% “Buy” opinion from Barchart. TEVA offers international diversification and is favored by both Wall Street and individual investors. Today’s Featured Stock Valued...

After years of range trading, NYMEX platinum futures broke out to the upside in 2025, more than doubling from the 2025 closing price. As the market heads into 2026, platinum could have room to rally if gold and silver price action are an indicator.

Cisco Systems generated strong free cash flow in Q3, and there is every indication that it will continue. But CSCO stock has been flat. Shorting out-of-the-money put options and buying in-the-money calls makes sense.

While you can swing for the fences, by measuring the risk geometry of HOOD stock, you can improve your odds of success with a more realistic proposition.